ArticleNature medicine2020

TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.

Daisuke Ennishi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.